BBNX
Beta Bionics, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$16.53
+9.46%Year over year
Reported trailing growth
- Revenue
- +43.7%
- EBITDA
- -10.4%
- EBIT
- -35.0%
- EPS
- +9.7%
- Free cash flow
- -9.0%
- Operating cash flow
- -4.9%
Forward estimates
Based on analyst estimates
- Revenue
- +22.7%
- EBITDA
- -6.7%
- EPS
- -12.9%
Three-year CAGR
- Revenue
- +724.3%
- EBITDA
- -34.0%
- EBIT
- -58.4%
- Net income
- -33.7%
- EPS
- -41.4%
- Free cash flow
- -8.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026